Published in AIDS Weekly, October 16th, 2000
The Center received the first installment, nearly $1.5 million, from the U.S. National Institute of Allergy and Infectious Diseases on September 25, 2000. About a third of the first installment will fund studies into disease development, latent HIV infection, immune restoration, and prevention.
The rest of the $1.5 million will be used to improve research facilities and communication systems used by researchers.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.